|
GS183109: GO:0034622 cellular macromolecular complex assembly
|
|
GS183848: GO:0044260 cellular macromolecule metabolic process
|
|
GS136891: voluntary alcohol consumption QTL 5 (Vacq5, Published QTL Chr 13)
|
|
GS180154: GO:0065004 protein-DNA complex assembly
|
|
GS208954: GO:0006139 nucleobase-containing compound metabolic process
|
|
GS34472: Whole Brain Gene expression correlates of Novel environment locomotion (activity beam breaks) 15-30 min in the periphery in BXD Females
|
|
GS35251: Striatum Gene expression correlates of Maximum startle response to 70 db in Females BXD
|
|
GS178461: GO:0009987 cellular process
|
|
GS189628: GO:0031497 chromatin assembly
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS186743: GO:0043227 membrane-bounded organelle
|
|
GS210507: GO:0006950 response to stress
|
|
GS26220: Striatum Gene expression correlates of Thermal Nociception Hargreaves' Test in Males BXD
|
|
GS123265: Estradiol interacting genes (MeSH:D004958) in CTD
|
|
GS36049: Neocortex Gene expression correlates of Light- Dark Box Total seconds spent in light compartment in Females & Males BXD
|
|
GS135384: body weight 1 (Bdw1, Published QTL Chr 13)
|
|
GS86911: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). Lists of probe sets and gene names altered by morphine treatment (661). [DRG]
provisional
|
|
GS193268: GO:0005575 cellular_component
|
|
GS194039: GO:1901363 heterocyclic compound binding
|
|
GS36541: Neocortex Gene expression correlates of Dowel Test - Time B Sec in Females & Males BXD
|
|
GS188190: GO:0006807 nitrogen compound metabolic process
|
|
GS34572: Whole Brain Gene expression correlates of Novel environment distance (cm) travelled minutes 0-15 in Females BXD
|
|
GS136884: testis weight QTL 1 (Twq1, Published QTL Chr 13)
|
|
GS123332: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide interacting genes (MeSH:D015123) in CTD
|
|
GS125757: Isoflavones interacting genes (MeSH:D007529) in CTD
|
|
GS136041: insulin dependent diabetes susceptibility 14 (Idd14, Published QTL Chr 13)
|
|
GS191019: GO:0034641 cellular nitrogen compound metabolic process
|
|
GS86515: Table S2: Additional data file 2 - Lists of probe sets of genes with expression altered by acute and chronic morphine (ANOVA; FDR < 1%). DBA/2J [DRG]
provisional
|
|
GS186436: GO:0071824 protein-DNA complex subunit organization
|
|
GS123595: Progesterone interacting genes (MeSH:D011374) in CTD
|
|
GS182313: GO:0044085 cellular component biogenesis
|
|
GS192986: GO:0006996 organelle organization
|
|
GS178814: GO:0046982 protein heterodimerization activity
|
|
GS179950: GO:0006259 DNA metabolic process
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS126646: Carbon Tetrachloride interacting genes (MeSH:D002251) in CTD
|
|
GS84151: METH responses for body temperature (Published QTL, Chr 3)
|
|
GS192017: GO:0006139 nucleobase-containing compound metabolic process
|
|
GS34871: Cerebellum Gene expression correlates of Open Field - Percentage center time in Females BXD
|
|
GS191106: GO:0044464 cell part
|
|
GS177570: GO:0016043 cellular component organization
|
|
GS186227: GO:0090304 nucleic acid metabolic process
|
|
GS201251: GO:0044424 intracellular part
|
|
GS178359: GO:0071840 cellular component organization or biogenesis
|
|
GS34587: Whole Brain Gene expression correlates of Novel environment distance (cm) travelled minutes 0-15 in BXD Females
|
|
GS122195: Gentamicins interacting genes (MeSH:D005839) in CTD
|
|
GS196932: GO:0065004 protein-DNA complex assembly
|
|
GS123171: hydroxyhydroquinone interacting genes (MeSH:C013038) in CTD
|
|
GS178357: GO:0071842 cellular component organization at cellular level
|
|
GS35028: Whole Brain Gene expression correlates of Novel Open Field - TOTAL locomotion (activity beam breaks) in the periphery in Females BXD
|
|
GS136135: lithogenic gene 15 (Lith15, Published QTL Chr 13)
|
|
GS184449: GO:0044427 chromosomal part
|
|
GS86561: Table S2: Additional data file 2 - Lists of probe sets of genes with expression altered by acute and chronic morphine (ANOVA; FDR < 1%). ALL [DRG]
provisional
|
|
GS87096: Table S2: List of Cocaine-Treated HDAC5 KO vs. Cocaine-Treated WT Significantly Regulated Genes. [DRG]
provisional
|
|
GS193888: GO:0051276 chromosome organization
|
|
GS203494: GO:0051704 multi-organism process
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS86785: Table S3: Presented are significant functional categories (GO terms) enriched with genes regulated in response to acute and / or chronic morphine, along with lists of probe sets and gene names classified to each GO category. [DRG]
provisional
|
|
GS136779: systolic blood pressure 2 (Sysbp2, Published QTL Chr 13)
|
|
GS36134: Neocortex Gene expression correlates of Activity during 1st tone shock pairing in Males BXD
|
|
GS189957: GO:0034728 nucleosome organization
|
|
GS86840: Table S3: Presented are significant functional categories (GO terms) enriched with genes regulated in response to acute and / or chronic morphine, along with lists of probe sets and gene names classified to each GO category. [DRG]
provisional
|
|
GS203594: GO:0043226 organelle
|
|
GS201592: GO:0009617 response to bacterium
|
|
GS198868: GO:0000786 nucleosome
|
|
GS197892: GO:0043228 non-membrane-bounded organelle
|
|
GS87399: Table S3: Presented are significant functional categories (GO terms) enriched with genes regulated in response to acute and / or chronic morphine, along with lists of probe sets and gene names classified to each GO category. (Whole Table) [DRG]
provisional
|
|
GS195643: GO:0003677 DNA binding
|
|
GS206500: GO:0031497 chromatin assembly
|
|
GS209928: GO:0006996 organelle organization
|
|
GS194527: GO:0006323 DNA packaging
|
|
GS186744: GO:0043226 organelle
|
|
GS194077: GO:0071103 DNA conformation change
|
|
GS198866: GO:0000785 chromatin
|
|
GS34620: Whole Brain Gene expression correlates of Novel environment distance (cm) travelled min 15-30 in BXD Females
|
|
GS182835: GO:0005622 intracellular
|
|
GS203593: GO:0043227 membrane-bounded organelle
|
|
GS181102: GO:0043228 non-membrane-bounded organelle
|
|
GS125799: Asbestos, Crocidolite interacting genes (MeSH:D017638) in CTD
|
|
GS135996: hippocampal weight 3 (Hipp3, Published QTL Chr 13)
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS127127: Benzo(a)pyrene interacting genes (MeSH:D001564) in CTD
|
|
GS35261: Striatum Gene expression correlates of Maximum startle response to 80 db in Females BXD
|
|
GS136221: mandible length 13 (Manln13, Published QTL Chr 13)
|
|
GS210000: GO:0044446 intracellular organelle part
|
|
GS136005: hapatic PMN infiltration 1 (Hpi1, Published QTL Chr 13)
|
|
GS127166: bisphenol A interacting genes (MeSH:C006780) in CTD
|
|
GS34233: Neocortex Gene expression correlates of Light-Dark Box Percentage of distance traveled in light compartment in Males BXD
|
|
GS194087: GO:0003674 molecular_function
|
|
GS186790: GO:0006725 cellular aromatic compound metabolic process
|
|
GS177356: GO:0003674 molecular_function
|
|
GS178885: GO:0003677 DNA binding
|
|
GS180149: GO:0065003 macromolecular complex assembly
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS194111: GO:0097159 organic cyclic compound binding
|
|
GS34243: Neocortex Gene expression correlates of Light-Dark Box Percentage time in light in Males BXD
|
|
GS84267: nicotine sensitivity (Published QTL, Chr 13)
|
|
GS177309: GO:1901363 heterocyclic compound binding
|
|
GS136931: vertebral trabecular bone trait 15 (Vtbt15, Published QTL Chr 13)
|
|
GS196927: GO:0065003 macromolecular complex assembly
|
|
GS86920: Table S3: Detailed description of Gene Ontology analysis presented in Table 1 and Table 2. Inter strain GO [DRG]
provisional
|
|
GS195199: GO:0005634 nucleus
|
|
GS180166: GO:0008152 metabolic process
|
|
GS194307: GO:0016043 cellular component organization
|
|
GS87137: Table S2: List of probe-sets of genes differentially expressed among the four inbred strains of mice. Gene Ranks [DRG]
provisional
|
|
GS195108: GO:0071844 cellular component assembly at cellular level
|
|
GS203072: GO:0090304 nucleic acid metabolic process
|
|
GS177382: GO:0097159 organic cyclic compound binding
|
|
GS135976: wound healing/regeneration 3 (Heal3, Published QTL Chr 13)
|
|
GS201253: GO:0044427 chromosomal part
|
|
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
|
|
GS195571: GO:0046982 protein heterodimerization activity
|
|
GS206909: GO:0006952 defense response
|
|
GS87045: Table S2: Additional data file 2 - Lists of probe sets of genes with expression altered by acute and chronic morphine (ANOVA; FDR < 1%). SWR/J [DRG]
provisional
|
|
GS129173: pregnancy QTL 3 (Pregq3 Published QTL Chr 13)
|
|
GS181473: GO:0005488 binding
|
|
GS199112: GO:0044085 cellular component biogenesis
|
|
GS196719: GO:0006259 DNA metabolic process
|
|
GS125090: monomethylarsonous acid interacting genes (MeSH:C406082) in CTD
|
|
GS180238: GO:0032993 protein-DNA complex
|
|
GS86517: Table S2: Additional data file 2 - Lists of probe sets of genes with expression altered by acute and chronic morphine (ANOVA; FDR < 1%). 129P3/J [DRG]
provisional
|
|
GS136341: nicotine induced locomotor activity 7 (Nilac7, Published QTL Chr 13)
|
|
GS195214: GO:0009987 cellular process
|
|
GS184452: GO:0044422 organelle part
|
|
GS195112: GO:0071840 cellular component organization or biogenesis
|
|
GS200648: GO:0044260 cellular macromolecule metabolic process
|
|
GS125526: 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane interacting genes (MeSH:C404910) in CTD
|
|
GS35241: Striatum Gene expression correlates of Maximum startle to 120 db in Females BXD
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS206657: GO:0043933 macromolecular complex subunit organization
|
|
GS125634: trichostatin A interacting genes (MeSH:C012589) in CTD
|
|
GS203642: GO:0006725 cellular aromatic compound metabolic process
|
|
GS207923: GO:0034641 cellular nitrogen compound metabolic process
|
|
GS86906: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). Lists of probe sets and gene names altered by strain (3457). [DRG]
provisional
|
|
GS34426: Whole Brain Gene expression correlates of Novel environment vertical activity counts minutes 0-15 in Females BXD
|
|
GS177346: GO:0071103 DNA conformation change
|
|
GS198263: GO:0005488 binding
|
|
GS194040: GO:1901360 organic cyclic compound metabolic process
|
|
GS194088: GO:0003676 nucleic acid binding
|
|
GS35271: Striatum Gene expression correlates of Maximum startle response to 85 db in Females BXD
|
|
GS35779: Neocortex Gene expression correlates of CPP - Time (s) in drug-paired compartment a in Males BXD
|
|
GS124711: Genistein interacting genes (MeSH:D019833) in CTD
|
|
GS124312: sodium arsenite interacting genes (MeSH:C017947) in CTD
|
|
GS125548: Doxorubicin interacting genes (MeSH:D004317) in CTD
|
|
GS178813: GO:0046983 protein dimerization activity
|
|
GS127207: 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone interacting genes (MeSH:C024709) in CTD
|
|
GS184447: GO:0044424 intracellular part
|
|
GS177784: GO:0006325 chromatin organization
|
|
GS194267: GO:0043170 macromolecule metabolic process
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS209863: GO:0050896 response to stimulus
|
|
GS195570: GO:0046983 protein dimerization activity
|
|
GS178360: GO:0071841 cellular component organization or biogenesis at cellular level
|
|
GS36292: Whole Brain Gene expression correlates of Open Field InovelTOTAL locomotion (activity beam breaks) in the center in BXD Females
|
|
GS125069: Sodium Selenite interacting genes (MeSH:D018038) in CTD
|
|
GS1228: Expression patterns of the 77 genes that differentially expressed between brains of wild-type and nAChR beta-4 subunit deficient mice
|
|
GS136440: peak bone density 2 (Pbd2, Published QTL Chr 13)
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS123768: Cyclosporine interacting genes (MeSH:D016572) in CTD
|
|
GS178975: GO:0022607 cellular component assembly
|
|
GS180164: GO:0008150 biological_process
|
|
GS177357: GO:0003676 nucleic acid binding
|
|
GS177531: GO:0043170 macromolecule metabolic process
|
|
GS178355: GO:0071844 cellular component assembly at cellular level
|
|
GS205255: GO:0044238 primary metabolic process
|
|
GS180236: GO:0032991 macromolecular complex
|
|
GS177787: GO:0006323 DNA packaging
|
|
GS190115: GO:0006334 nucleosome assembly
|
|
GS203283: GO:0071824 protein-DNA complex subunit organization
|
|
GS123048: Tretinoin interacting genes (MeSH:D014212) in CTD
|
|
GS208012: GO:0044464 cell part
|
|
GS87380: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). (Whole Table) [DRG]
|
|
GS210212: GO:0005575 cellular_component
|
|
GS201239: GO:0046483 heterocycle metabolic process
|
|
GS190116: GO:0006333 chromatin assembly or disassembly
|
|
GS188399: GO:0044238 primary metabolic process
|
|
GS207006: GO:0006333 chromatin assembly or disassembly
|
|
GS122305: resveratrol interacting genes (MeSH:C059514) in CTD
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS184435: GO:0046483 heterocycle metabolic process
|
|
GS195113: GO:0071841 cellular component organization or biogenesis at cellular level
|
|
GS182076: GO:0000786 nucleosome
|
|
GS199906: GO:0034621 cellular macromolecular complex subunit organization
|
|
GS121614: Cyclic AMP interacting genes (MeSH:D000242) in CTD
|
|
GS197018: GO:0032993 protein-DNA complex
|
|
GS135550: CD4 T cell subset 6 (Cd4ts6, Published QTL Chr 13)
|
|
GS123916: Aflatoxin B1 interacting genes (MeSH:D016604) in CTD
|
|
GS177310: GO:1901360 organic cyclic compound metabolic process
|
|
GS195733: GO:0022607 cellular component assembly
|
|
GS203491: GO:0051707 response to other organism
|
|
GS124592: Methylmethacrylate interacting genes (MeSH:D020366) in CTD
|
|
GS182834: GO:0005623 cell
|
|
GS121965: Amiodarone interacting genes (MeSH:D000638) in CTD
|
|
GS124295: Polychlorinated Biphenyls interacting genes (MeSH:D011078) in CTD
|
|
GS197016: GO:0032991 macromolecular complex
|
|
GS178448: GO:0005634 nucleus
|
|
GS182474: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS199635: GO:0005622 intracellular
|
|
GS136303: modifier of Salmonella typhimurium susceptibility 4 (Msts4, Published QTL Chr 13)
|
|
GS34440: Whole Brain Gene expression correlates of Novel environment vertical activity counts minutes 0-15 in BXD Females
|
|
GS185937: GO:0005694 chromosome
|
|
GS196943: GO:0008152 metabolic process
|
|
GS87381: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). (Whole Table) [DRG]
provisional
|
|
GS196941: GO:0008150 biological_process
|
|
GS199634: GO:0005623 cell
|
|
GS207271: GO:0042742 defense response to bacterium
|
|
GS201256: GO:0044422 organelle part
|
|
GS86497: Table S2: Additional data file 2 - Lists of probe sets of genes with expression altered by acute and chronic morphine (ANOVA; FDR < 1%). C57BL/6J [DRG]
provisional
|
|
GS201431: GO:0005515 protein binding
|
|
GS208107: GO:0009607 response to biotic stimulus
|
|
GS206837: GO:0034728 nucleosome organization
|
|
GS126276: pirinixic acid interacting genes (MeSH:C006253) in CTD
|
|
GS177169: GO:0051276 chromosome organization
|
|
GS35011: Cerebellum Gene expression correlates of Open Field-Total time in perimeter in Females BXD
|
|
GS195110: GO:0071842 cellular component organization at cellular level
|
|
GS193059: GO:0044446 intracellular organelle part
|
|
GS84268: nicotine sensitivity (Published QTL, Chr 13)
|
|
GS136029: hypertension (Hypt, Published QTL Chr 13)
|
|
GS182074: GO:0000785 chromatin
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS129100: bone mineral density 3 (Bmd3 Published QTL Chr 13)
|
|
GS199909: GO:0034622 cellular macromolecular complex assembly
|
|
GS136606: spacial bias during navigation task 2 (Sbnt2, Published QTL Chr 13)
|
|
GS136469: p-glycoprotein positive CD4 T cell subset 2 (Pcd4ts2, Published QTL Chr 13)
|
|
GS183106: GO:0034621 cellular macromolecular complex subunit organization
|
|
GS199272: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS194524: GO:0006325 chromatin organization
|
|
GS205047: GO:0006807 nitrogen compound metabolic process
|
|
GS87101: Table S4: List of Saline-Treated HDAC5 KO vs. Saline-Treated WT Significantly Regulated Genes. [DRG]
provisional
|
|
GS184629: GO:0005515 protein binding
|
|
GS36019: Neocortex Gene expression correlates of Light-Dark Box Total seconds spent in dark compartment in Females & Males BXD
|
|
GS202775: GO:0005694 chromosome
|
|
GS84150: ethanol conditioned taste aversion (Published QTL, Chr 3)
|
|
GS207004: GO:0006334 nucleosome assembly
|
|
GS189780: GO:0043933 macromolecular complex subunit organization
|